Artículo Original
Uso de la alitretinoína oral para el tratamiento del eczema crónico de manos grave y refractario al tratamiento en el sistema sanitario público español: descripción y análisis de la práctica clínica actual
Oral Alitretinoin in the Treatment of Severe Refractory Chronic Hand Eczema in the Spanish National Health System: Description and Analysis of Current Clinical Practice
Leído
10137
Vecesse ha leído el artículo
2627
Total PDF
7510
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 110 | 14 | 124 |
| 2025 5 | 188 | 42 | 230 |
| 2025 4 | 176 | 25 | 201 |
| 2025 3 | 158 | 30 | 188 |
| 2025 2 | 160 | 34 | 194 |
| 2025 1 | 130 | 24 | 154 |
| 2024 12 | 158 | 25 | 183 |
| 2024 11 | 165 | 59 | 224 |
| 2024 10 | 122 | 44 | 166 |
| 2024 9 | 159 | 38 | 197 |
| 2024 8 | 175 | 75 | 250 |
| 2024 7 | 140 | 29 | 169 |
| 2024 6 | 159 | 40 | 199 |
| 2024 5 | 109 | 30 | 139 |
| 2024 4 | 143 | 35 | 178 |
| 2024 3 | 129 | 29 | 158 |
| 2024 2 | 105 | 31 | 136 |
| 2024 1 | 92 | 38 | 130 |
| 2023 12 | 82 | 27 | 109 |
| 2023 11 | 112 | 30 | 142 |
| 2023 10 | 110 | 15 | 125 |
| 2023 9 | 144 | 34 | 178 |
| 2023 8 | 129 | 16 | 145 |
| 2023 7 | 145 | 35 | 180 |
| 2023 6 | 111 | 26 | 137 |
| 2023 5 | 119 | 21 | 140 |
| 2023 4 | 107 | 33 | 140 |
| 2023 3 | 120 | 23 | 143 |
| 2023 2 | 118 | 31 | 149 |
| 2022 1 | 102 | 36 | 138 |
| 2022 12 | 84 | 34 | 118 |
| 2022 11 | 130 | 44 | 174 |
| 2022 10 | 127 | 43 | 170 |
| 2022 9 | 98 | 50 | 148 |
| 2022 8 | 104 | 61 | 165 |
| 2022 7 | 100 | 72 | 172 |
| 2022 6 | 100 | 35 | 135 |
| 2022 5 | 103 | 47 | 150 |
| 2022 4 | 132 | 41 | 173 |
| 2022 3 | 160 | 53 | 213 |
| 2022 2 | 144 | 32 | 176 |
| 2021 1 | 151 | 55 | 206 |
| 2021 12 | 80 | 40 | 120 |
| 2021 11 | 110 | 48 | 158 |
| 2021 10 | 80 | 58 | 138 |
| 2021 9 | 81 | 27 | 108 |
| 2021 8 | 62 | 21 | 83 |
| 2021 7 | 65 | 36 | 101 |
| 2021 6 | 66 | 54 | 120 |
| 2021 5 | 85 | 40 | 125 |
| 2021 4 | 193 | 83 | 276 |
| 2021 3 | 150 | 51 | 201 |
| 2021 2 | 92 | 77 | 169 |
| 2020 1 | 74 | 32 | 106 |
| 2020 12 | 71 | 31 | 102 |
| 2020 11 | 82 | 26 | 108 |
| 2020 10 | 59 | 25 | 84 |
| 2020 9 | 66 | 17 | 83 |
| 2020 8 | 76 | 30 | 106 |
| 2020 7 | 64 | 17 | 81 |
| 2020 6 | 59 | 47 | 106 |
| 2020 5 | 62 | 47 | 109 |
| 2020 4 | 78 | 28 | 106 |
| 2020 3 | 66 | 24 | 90 |
| 2020 2 | 19 | 16 | 35 |
| 2020 1 | 8 | 7 | 15 |
| 2019 12 | 14 | 7 | 21 |
| 2019 11 | 4 | 5 | 9 |
| 2019 10 | 3 | 9 | 12 |
| 2019 9 | 5 | 10 | 15 |
| 2019 8 | 11 | 16 | 27 |
| 2019 7 | 5 | 17 | 22 |
| 2019 6 | 16 | 23 | 39 |
| 2019 5 | 8 | 26 | 34 |
| 2019 4 | 20 | 19 | 39 |
| 2019 3 | 6 | 10 | 16 |
| 2019 2 | 14 | 8 | 22 |
| 2019 1 | 4 | 4 | 8 |
| 2018 12 | 14 | 1 | 15 |
| 2018 11 | 10 | 1 | 11 |
| 2018 10 | 3 | 5 | 8 |
| 2018 9 | 5 | 0 | 5 |
| 2018 8 | 1 | 0 | 1 |
| 2018 6 | 0 | 1 | 1 |
| 2018 5 | 1 | 0 | 1 |
| 2018 4 | 0 | 1 | 1 |
| 2018 3 | 1 | 2 | 3 |
| 2018 2 | 6 | 1 | 7 |
| 2018 1 | 6 | 1 | 7 |
| 2017 12 | 8 | 4 | 12 |
| 2017 11 | 10 | 1 | 11 |
| 2017 10 | 4 | 1 | 5 |
| 2017 9 | 9 | 1 | 10 |
| 2017 8 | 4 | 0 | 4 |
| 2017 7 | 4 | 1 | 5 |
| 2017 6 | 9 | 0 | 9 |
| 2017 5 | 4 | 2 | 6 |
| 2017 4 | 6 | 1 | 7 |
| 2017 3 | 5 | 0 | 5 |
| 2017 2 | 2 | 2 | 4 |
| 2016 1 | 3 | 1 | 4 |
| 2016 12 | 11 | 3 | 14 |
| 2016 11 | 10 | 4 | 14 |
| 2016 10 | 3 | 7 | 10 |
| 2016 9 | 2 | 9 | 11 |
| 2016 8 | 1 | 3 | 4 |
| 2016 7 | 0 | 1 | 1 |
| 2016 6 | 0 | 1 | 1 |
Mostrar todo
